• About
  • Partnerships
  • Challenges
  • Awards
  • Grant Opportunities
  • News

Development of a Non-Infectious Poliovirus Vaccine

James Flanegan of the University of Florida in the U.S. proposes to develop a non-infectious poliovirus vaccine using encapsidated replicons or mature empty capsids that retain full immunogenicity. Either approach can be potentially used to develop a new vaccine that can be safely used in a pre- or post-eradication world.

More information about The Poliovirus Endgame: Create ways to Accelerate, Sustain and Monitor Eradication (Round 6)

Great ideas come from everywhere.

Sign up for email updates of the latest grant opportunities and awards.

View the Grand Challenges partnership network

The Bill & Melinda Gates Foundation is part of the Grand Challenges partnership network. Visit www.grandchallenges.org to view the map of awarded grants across this network and grant opportunities from partners.